To further evaluate the significance of the mutation frequency of PRRT2 and DAB2IP in clinical MSI colorectal and endometrial cancer patient samples, we compared their frequency to the average mutation frequency for common MSI target genes published in databases (SelTarbase [31]) (Supplementary Table 7). This evidence concerns the gene PRRT2 and endometrial cancer.